Stay updated on Dupilumab for AKC: Efficacy Study Clinical Trial
Sign up to get notified when there's something new on the Dupilumab for AKC: Efficacy Study Clinical Trial page.

Latest updates to the Dupilumab for AKC: Efficacy Study Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page footer.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; this is a minor update with no visible changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check78 days agoChange DetectedAdded Andover Eye Associates as a collaborator/sponsor and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check85 days agoChange DetectedAdded a 'Show glossary' option and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Minor wording/capitalization updates to FEAR Act data references and removal of older QC/version references (e.g., 'Last Update Submitted that met QC Criteria' and 'Revision: v3.3.4').SummaryDifference0.2%

Stay in the know with updates to Dupilumab for AKC: Efficacy Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab for AKC: Efficacy Study Clinical Trial page.